Clinical Study
Completely Resected N0 Non-Small Cell Lung Cancer: Prognostic Factors Affecting Long-Term Survival
Table 2
Treatments and pathological reports.
| Parameters | (%) |
| Surgical procedures | | Lobectomy | 114 (91.9) | Bilobectomy (RUL and RML) | 1 (0.8) | Bilobectomy (RLL and RML) | 9 (7.3) | Histologic types | | Adenocarcinoma | 70 (56.5) | Squamous cell carcinoma | 33 (26.6) | Bronchioloalveolar carcinoma | 10 (8.1) | Large cell carcinoma | 5 (4.0) | Neuroendocrine tumor | 3 (2.4) | Adenoid cystic CA | 2 (1.6) | Adenosquamous | 1 (0.8) | Tumor grading | | Well differentiated | 41 (33.1) | Moderately differentiated | 45 (36.3) | Poorly differentiated | 24 (19.4) | Undifferentiated | 5 (4.0) | Mucinous type (BAC) | 5 (4.0) | Nonmucinous type (BAC) | 4 (3.2) | Pathological staging | | IA | 33 (26.6) | IB | 45 (36.3) | IIA | 21 (16.9) | IIB | 25 (20.2) | Tumor diameter (cm) | | ≤3 | 33 (26.6) | >3 | 91 (73.4) | Tumor necrosis | 48 (38.7) | Visceral pleural invasion | 23 (18.6) | Neural invasion | 2 (1.6) | Intratumoral lymphatic invasion | 91 (73.4) | Intratumoral blood vessel invasion | 40 (32.3) | Follow-up time (months) | | Tumor recurrence | 53 (42.7) | Death | 47 (37.9) |
|
|